Add to ORKGSynovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics DENNIS, Glynn (Jr), et al. Rheumatoid arthritis (RA) is a complex and clinically heterogeneous autoimmune disease. Currently, the relationship between pathogenic molecular drivers of disease in RA and therapeutic response is poorly understood. DENNIS, Glynn (Jr), et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Research and Therapy, 2014, vol. 16, no. 2, p. R9
INTRODUCTION: The extensive knowledge gained in the cellular and molecular mechanisms underlying Rhe...
Approximately 30 % of rheumatoid arthritis patients achieve inadequate response to anti-TNF biologic...
14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damag...
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics outcome...
Rheumatoid arthritis (RA) is a complex and clinically heterogeneous autoimmune disease. Currently, t...
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting synovial tissue in multiple jo...
Objectives Early diagnosis of rheumatoid arthritis (RA) is an unmet medical need in the field of rhe...
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease targeting the joints. Current t...
Rheumatoid arthritis (RA) is a progressive inflammatory disease with severe symptoms of pain and sti...
Objectives To determine whether genetic variation within genes related to the Toll-like receptor, in...
Objective: To define the relationship of synovial B cells to clinical phenotypes at different s...
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease characterized by a predominan...
with disease activity and h ag Rheumatoid arthritis (RA) is a chronic inflammatory dis-ease characte...
Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease. RA mainly affects synovial joint...
OBJECTIVES: Early diagnosis of rheumatoid arthritis (RA) is an unmet medical need in the field of rh...
INTRODUCTION: The extensive knowledge gained in the cellular and molecular mechanisms underlying Rhe...
Approximately 30 % of rheumatoid arthritis patients achieve inadequate response to anti-TNF biologic...
14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damag...
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics outcome...
Rheumatoid arthritis (RA) is a complex and clinically heterogeneous autoimmune disease. Currently, t...
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting synovial tissue in multiple jo...
Objectives Early diagnosis of rheumatoid arthritis (RA) is an unmet medical need in the field of rhe...
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease targeting the joints. Current t...
Rheumatoid arthritis (RA) is a progressive inflammatory disease with severe symptoms of pain and sti...
Objectives To determine whether genetic variation within genes related to the Toll-like receptor, in...
Objective: To define the relationship of synovial B cells to clinical phenotypes at different s...
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease characterized by a predominan...
with disease activity and h ag Rheumatoid arthritis (RA) is a chronic inflammatory dis-ease characte...
Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease. RA mainly affects synovial joint...
OBJECTIVES: Early diagnosis of rheumatoid arthritis (RA) is an unmet medical need in the field of rh...
INTRODUCTION: The extensive knowledge gained in the cellular and molecular mechanisms underlying Rhe...
Approximately 30 % of rheumatoid arthritis patients achieve inadequate response to anti-TNF biologic...
14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damag...